INS and Hypoglycemia: In a multivariable linear regression model including all the significant factors mentioned above, insulin treatment prior to 36 weeks PMA was significantly associated with longer time spent in hypoglycemia at 36 weeks PMA (B 68.607, CI 9.932–127.283, P = 0.023).